Case of respiratory discomfort due to myositis after administration of nivolumab

被引：57

作者：

Yoshioka, Miri ^{[1
]}

Kambe, Naotomo ^{[1
]}

Yamamoto, Yosuke ^{[1
]}

Suehiro, Keisuke ^{[1
]}

Matsue, Hiroyuki ^{[1
]}

机构：

[1] Chiba Univ, Dept Dermatol, Grad Sch Med, Chiba 2608670, Japan

来源：

JOURNAL OF DERMATOLOGY | 2015年 / 42卷 / 10期

关键词：

D O I：

10.1111/1346-8138.12991

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1008 / 1009

页数：2

共 5 条

[1] PD-1 as a potential target in cancer therapy
McDermott, David F.
Atkins, Michael B.
[J]. CANCER MEDICINE, 2013, 2 (05): : 662 - 673
[2] Anti-PD1 Following Ipilimumab for Mucosal Melanoma: Durable Tumor Response Associated with Severe Hypothyroidism and Rhabdomyolysis
Min, Le
Hodi, F. Stephen
[J]. CANCER IMMUNOLOGY RESEARCH, 2014, 2 (01) : 15 - 18
[3] Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Topalian, Suzanne L.
Sznol, Mario
McDermott, David F.
Kluger, Harriet M.
Carvajal, Richard D.
Sharfman, William H.
Brahmer, Julie R.
Lawrence, Donald P.
Atkins, Michael B.
Powderly, John D.
Leming, Philip D.
Lipson, Evan J.
Puzanov, Igor
Smith, David C.
Taube, Janis M.
Wigginton, Jon M.
Kollia, Georgia D.
Gupta, Ashok
Pardoll, Drew M.
Sosman, Jeffrey A.
Hodi, F. Stephen
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (10) : 1020 - +
[4] Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Topalian, Suzanne L.
Hodi, F. Stephen
Brahmer, Julie R.
Gettinger, Scott N.
Smith, David C.
McDermott, David F.
Powderly, John D.
Carvajal, Richard D.
Sosman, Jeffrey A.
Atkins, Michael B.
Leming, Philip D.
Spigel, David R.
Antonia, Scott J.
Horn, Leora
Drake, Charles G.
Pardoll, Drew M.
Chen, Lieping
Sharfman, William H.
Anders, Robert A.
Taube, Janis M.
McMiller, Tracee L.
Xu, Haiying
Korman, Alan J.
Jure-Kunkel, Maria
Agrawal, Shruti
McDonald, Daniel
Kollia, Georgia D.
Gupta, Ashok
Wigginton, Jon M.
Sznol, Mario
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) : 2443 - 2454
[5] Yamazaki N, 2013, EUR J CANCER, V49, pS868

← 1 →